Reflections on the US FDA's warning on direct-to-consumer genetic testing

Abstract:

In November 2013, the US Food and Drug Administration (FDA) sent a warning letter to 23andMe, Inc. and ordered the company to discontinue marketing of the 23andMe Personal Genome Service (PGS) until it receives FDA marketing authorization for the...

Type:

Journal Article

Date:

2014

Authors and Contributors:

Seon-Hee Yim Yeun-Jun Chung

Pages:

151-155

Site link:

Read the Journal Article: Reflections on the US FDA's warning on direct-to-consumer genetic testing

URL Citation:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330248/

DOI:

10.5808/GI.2014.12.4.151

Issue:

4

Volume:

12

Publication:

Genomics & Informatics

LawSeq^SM Record Last Modified:

08/17/2018